- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2010
- Public Summary Document (PSD) November 2010 PBAC Meeting - PDF
Adalimumab – November 2010
Adalimumab, injection, 40 mg in 0.8 mL, pre-filled syringe, pre-filled pen, Humira® - November 2010
Last updated
2 March 2011